Senchyna; Diane Michelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for Senchyna; Diane Michelle.The latest application filed is for "rnai-mediated inhibition of tumor necrosis factor alpha-related conditions".

Company Profile

2.6.9

Senchyna; Diane Michelle - Corona del Mar CA
Senchyna; Diane Michelle - Fort Worth TX
Senchyna; Diane Michelle - Waterloo CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Intranasal stimulation for treatment of meibomian gland disease and blepharitis Grant 10,918,864 - Franke , et al. February 16, 2	2021-02-16
RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions App 20190032061 - Yanni; John M. ; et al.	2019-01-31
Extranasal Stimulation Devices And Methods App 20180161579 - FRANKE; Manfred ; et al.	2018-06-14
Intranasal Stimulation For Treatment Of Meibomian Gland Disease And Blepharitis App 20170312521 - FRANKE; Manfred ; et al.	2017-11-02
RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions App 20160369283 - Yanni; John M. ; et al.	2016-12-22
RNAi-mediated inhibition of tumor necrosis factor .alpha.-related conditions Grant 9,447,419 - Yanni , et al. September 20, 2	2016-09-20
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS App 20140357694 - Yanni; John M. ; et al.	2014-12-04
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS App 20130338213 - Yanni; John M. ; et al.	2013-12-19
RNAi-mediated inhibition of tumor necrosis factor .alpha.-related conditions Grant 8,541,389 - Yanni , et al. September 24, 2	2013-09-24
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS App 20110142767 - Yanni; John M. ; et al.	2011-06-16
RNAI-mediated inhibition of tumor necrosis factor .alpha.-related conditions Grant 7,732,421 - Yanni , et al. June 8, 2	2010-06-08
Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye Grant 7,381,708 - Taylor , et al. June 3, 2	2008-06-03
Rnai-mediated Inhibition Of Tumor Necrosis Factor Alpha-related Conditions App 20070281901 - Yanni; John M. ; et al.	2007-12-06
Suppression of eIF5A1 expression to prevent retinal ganglion cell death in the glaucomatous eye App 20030225022 - Taylor, Catherine ; et al.	2003-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.